2.21 USD
↗ 0.00 (0.18%)PRE MARKET (AS OF 04:02 AM EDT)
NervGen Pharma Corp. Common stock
NGENNASDAQ • USD
Market: OPEN
NervGen Pharma Corp. Common stock (NGEN) trades at $2.21 per share. Technical indicators currently signal "Buy". This is driven by a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$2.21
High?$2.21
Low?$2.21
Prev. Close?$2.21
Volume?N/A
Avg. Volume?N/A
Bid / Ask
Bid?$1.76 × 100
Ask?$2.51 × 100
Spread?$0.75
Midpoint?$2.14
Valuation & Ratios
Market Cap?223.6M
Shares Out?80.6M
Float?63.9M
Float %?79.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?8.35%Elevated
Short Interest?5.3M
Days to Cover?13.8
Free Float63.9M
Avg Daily Volume385.8K
Settlement Date2026-08-14